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Abstract: Bone morphogenetic proteins (BMPs) control many developmental and 
physiological processes, including skeleton formation and homeostasis. Previous studies in 
zebrafish revealed the crucial importance of proper BMP signaling before 48 h post-fertilization 
(hpf) for cartilage formation in the skull. Here, we focus on the involvement of the BMP 
pathway between 48 and 96 hpf in bone formation after 96 hpf. Using BMP inhibitors and 
the expression of a dominant-negative BMP receptor, we analyze whether the loss of BMP 
signaling affects osteoblastogenesis, osteoblast function and bone mineralization. To this 
end, we used the transgenic zebrafish line Tg(osterix:mCherry), detection of nitric oxide 
(NO) production, and alizarin red staining, respectively. We observed that inhibition of 
BMP signaling between 48 and 72 hpf led to a reduction of NO production and bone 
mineralization. Osteoblast maturation and chondrogenesis, on the other hand, seemed 
unchanged. Osteoblast function and bone formation were less affected when BMP 
signaling was inhibited between 72 and 96 hpf. These results suggest that for the onset of 
bone formation, proper BMP signaling between 48 and 72 hpf is crucial to ensure 
osteoblast function and ossification. Furthermore, detection of NO in developing zebrafish 
larvae appears as an early indicator of bone calcification activity. 
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In zebrafish, major parts of the craniofacial skeleton derive from cranial neural crest cells (cNCCs) 
that previously migrated from the dorsal edge of the neural tube to differentiate into chondrocytes 
within the ventrally located pharyngeal arches [1]. Each pharyngeal arch is formed by a mesoderm-derived 
core embedded in the neural crest-derived cartilage precursor cells and is surrounded medially by 
endoderm and laterally by ectoderm. For formation of perichondral bone elements, the cartilage 
structures are populated with osteoblastic cells that will finally secrete the bone matrix. Depending on 
hedgehog signaling, the chondrocytes themselves or peripheral cells are recruited to that end [2]. Other 
(dermal) bone elements are directly formed by osteoblasts derived from mesenchymal cells, without  
a previous cartilage matrix. In mammals, one of the major genes involved in osteoblast differentiation 
is Runx2, similar to its zebrafish ortholog runx2b [3]. Further marker genes expressed in these  
bone-forming cells code for the transcription factor Osterix (Osx) [4] and bone extracellular matrix 
(ECM) proteins osteocalcin (Osc2) [5], collagen10a1 (Col10a1a) and collagen1a1a (Col1a1a) [6,7]. 
Finally, correct calcification of the bone ECM depends on transcellular epithelial calcium uptake 
through the calcium channel Trpv5/6 [8] and the precise control of phosphate/pyrophosphate 
homeostasis by the osteoblast-specific Entpd5 diphosphohydrolase [9] or the widely expressed 
phosphodiesterase Enpp1 [10]. 
In vertebrates, the bone morphogenetic protein (BMP) signaling pathway is known to play an 
essential role in many early developmental processes such as gastrulation or neurulation [11], but also 
in skeletogenesis [12]. BMP ligands bind to their transmembrane receptor complex, consisting of a 
type I and a type II receptor, to induce phosphorylation of the type I receptor. The activated receptor 
(Alk1, 2, 3, or 6) then phosphorylates Smad1, 5, and/or 8 which in turn associate with their common 
partner, Smad4 to migrate into the nucleus and regulate target genes [13]. Craniofacial defects were 
reported in conditional knock-out mice lacking BMP type I receptor Alk2 [14] or Smad4 [15] in 
cNCC, or in transgenic mice expressing the antagonistic Smad7 in cNCC cells [16]. In mammals, 
BMP2 is an important positive regulator for osteoblast differentiation by stimulating Osterix and 
Runx2 expression via Dlx5 [17,18]. Similar to the human bone disorder osteogenesis imperfecta, 
zebrafish harboring a mutation in the bmp1a gene display a higher mineral content of mature bone 
probably due to a negative effect on the ability to generate mature collagen fibrils [19]. In zebrafish, 
several members of the BMP ligand family, such as Bmp2a, Bmp2b Bmp4, Bmp5, Bmp7 were shown 
to be secreted in the pharyngeal region [12,20,21] and their importance for head cartilage development 
was shown [22]. Recently, BMPs were shown to promote ventral fates of the craniofacial skeleton in 
zebrafish before 24 hpf [23]. At later stages (30–36 hpf), the precise control of the expression of the 
fsta gene, encoding a BMP antagonist, in pharyngeal endoderm was shown to be required for the 
optimal amount of BMP signaling, required for proper chondrocyte differentiation and pharyngeal 
cartilage formation. Thus, the role of BMP signaling in skeleton formation has been extensively 
studied during the first two days of development, however little is known about its role at later stages, 
beyond 48 hpf. 
Here, we show that BMP signaling is required between 48 and 72 hpf, and to a lesser extent 
between 72 and 96 hpf, for bone mineralization in the head skeleton. Inhibition of BMP signaling 
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mainly affects osteoblast function, as assessed by monitoring their nitric oxide (NO) production, 
without affecting their proliferation or terminal differentiation. 
2. Results 
2.1. Inhibition of BMP Signaling Starting at 2 or 3 dpf Stages Affects Bone Mineralization 
To assess the role of BMP signaling in head skeleton formation at later stages of development 
without affecting earlier processes, we investigated the effects of dorsomorphin, an inhibitor of ALK2, 
BMPR-IA and BMPR-IB signaling and of BMP-induced Smad1/5/8 phosphorylation [24] at different 
stages beyond 48 hpf. 
 
Figure 1. Effects of the BMP inhibitor dorsomorphin on bone mineralization. Alizarin red 
staining of 5 dpf larvae treated at 2, 3 or 4 dpf during 24 h with 100 µM dorsomorphin. 
Control embryos were treated with DMSO. Embryos treated at 2 dpf (B lateral view and  
D ventral view) show severe reduction of all mineralized bone pieces compared to the controls 
(A lateral view and C ventral view). The treatments starting at 3 dpf (F in ventral view) 
and 4 dpf (H in ventral view) lead to a reduction of bone mineralization, but to a lesser 
extent than at 2 dpf compared to the controls embryos (respectively E and G in ventral 
view). c: cleithrum; en: entopterygoid; o: operculum; p: parasphenoid. Scale bar: 200 µM. 
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Treatment of embryos with 100 μM dorsomorphin was performed for 3 different periods: between 
48 and 72 hpf (2–3 dpf), between 72 and 96 hpf (3–4 dpf) and between 96 and 144 hpf (4–5 dpf), and 
cranial ossification was analyzed by Alizarin Red staining at 5 dpf (Figures 1 and S1). Treatment 
during 2–3 dpf lead to a clear reduction in calcification of all the bone elements in more than 95% of 
the larvae, treatment during 3–4 dpf caused minor defects mainly in the branchiostegal rays 1, while 
treatment during 4–5 dpf caused no detectable defects relative to the corresponding controls (Figures 1 
and S1). 
Although dorsomorphin was the first inhibitor of BMP signaling to be discovered [24], it was later 
shown to also inhibit vEGFR2 and AMPK signaling [25–27]. New generation BMP inhibitors were 
thus developed, among which the compound K02288 that presents a high specificity for BMP type I 
receptors, ALK1, 2, 3, and 6 [28] and was shown to induce dorsalization in early embryos at 8–10 µM 
concentrations. When we tested K02288 treatment on developing zebrafish larvae at two different 
concentrations, we observed a clear decrease in bone calcification at both 10 or 20 µM upon exposure 
from 2–3 dpf, while only a weak effect was observed following a 3–4 dpf treatment at 10 (not shown) 
or 20 µM K02288 (Figures 2 and S2). Higher concentrations (40 µM) resulted in generation of 
morphological defects, such as cardiac edema, and were thus not considered. 
 
Figure 2. Effects of the specific BMP inhibitor K02288 on bone mineralization. Alizarine 
red staining of 5 dpf larvae previously treated at 2 (B,D) or 3 dpf (F) during 24 h with 
K02288 10 (B) and 20 µM (D,F). Control embryos (A,C,E) were treated with DMSO.  
c: cleithrum; en: entopterygoid; o: operculum; p: parasphenoid. Scale bar: 200 µM. 
To evaluate the specificity of the observed effects for bone formation, we also checked formation of 
the cartilage skeleton that serves as matrix for most of the cranial bone formation. Treatment with 
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dorsomorphin or K02288 was performed from 2–3 dpf and cartilage extracellular matrix was stained 
with Alcian Blue at 5 dpf (Figures 3 and S3). No defect was observed in the cranial cartilage formation, 
suggesting that BMP signaling at later stages mainly acts on bone formation (Figures 3 and S3). Whole 
mount in situ hybridization on 5 dpf revealed a similar expression pattern for the cartilage-specific 
sox9a gene in control and inhibitor treated larvae (Figure 3E–H, arrows). In living embryos, cartilage 
formation can additionally be assessed by nitric oxide labeling [29] (see below). 
 
 
Figure 3. (A–D) Effects of BMP inhibitor treatment at 2–3 dpf on cartilage formation. Alcian 
blue staining of 5 dpf larvae previously treated at 2 dpf during 24 h with 100 µM 
dorsomorphin (B) or 20 µM K02288 (D). Control embryos (A,C) were treated with 
DMSO; (E–H) In situ hybridization using the sox9a probe. No difference in cartilage 
formation was observed between control (E,G) and treated (F,H). cb 1–4: ceratobranchial 
ray 1 to 4; ch: ceratohyal; mk: Meckel’s cartilage. Scale bar: 200 µM. 
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2.2. Type I BMP Receptors Are Required for Osteoblast Formation and Function 
Secretion of the bone extracellular matrix and subsequent mineralization requires the presence and 
activity of mature osteoblasts. We therefore decided to investigate whether osteoblast differentiation 
and/or function would be affected by inhibition of BMP signaling. One of the most prominent marker 
genes for osteoblast differentiation, both in mammals and in teleosts, is the Osterix gene osx [4,30,31]. 
The transgenic zebrafish line Tg(osterix:mCherry) contains the coding sequence for the red fluorescent 
protein mCherry under the control of the medaka osterix promoter, thus allowing detection of 
osteoblasts in living larvae. When we treated these transgenic larvae at 2 dpf with dorsomorphin or 
K202288, we observed a similar pattern of expression both in treated and control larvae at 5 dpf 
(Figure 4C,D,F,I,J,L), suggesting that osteoblast proliferation and terminal differentiation were not 
affected by this treatment. Only the most anterior structures, the dentary and maxillary were less 
intensely fluorescent in the treated larvae. Since the number of differentiated osteoblasts in the cranial 
skeleton did not seem to be generally affected by BMP inhibition, we decided to probe the function of 
these osteoblasts. In addition to producing and secreting ECM proteins such as collagens, osteocalcin 
or osteopontin, one striking feature of these cells in the developing embryo is their production of nitric 
oxide (NO). 
Indeed, detection of NO in 5 dpf larvae using the green fluorescent label DAF-FM DA reveals 
strong staining of all the cranial bone elements and weak staining of cartilage structures; only the 
developing heart is stained to a similar extent (Figure 4A, arrow) [29]. NO detection in larvae treated 
at 2 dpf for 24 h with dorsomorphine or K02288 revealed a decrease of NO production in all bone 
elements (Figure 4A,B,E,G,H,K). The weak staining of cartilage structures was not affected. 
 
Figure 4. Cont. 




Figure 4. Effects of dorsomorphin (A–F) and K02288 (G–L) on NO production and osterix 
expression. (A,B,G,H) Nitric oxide labelling by DAF-FM DA of 5 dpf Tg (osx:mcherry) 
larvae previously treated during 24 h with 100 µM dorsomorphin (B) or 20 µM K02288 
(H) at 2 dpf. (C,D,I,J) mCherry red fluorescence of 5 dpf Tg (osx:mcherry) larvae previously 
treated during 24 h with 100 µM dorsomorphin (D) or 20 µM K02288 (H) at 2 dpf. Control 
embryos (A,C,G,I) were treated with DMSO. c: cleithrum; en: entopterygoid; o: 
operculum; p: parasphenoid. Scale bar: 200 µM. (E,F,K,L) Statistical analysis of replicate 
experiments investigating the effect of dorsomorphin (E, F) or K02288 (K,L) on nitric 
oxide (E,K) or mCherry (F, L) detection. *** indicates p-value < 0.005. 
2.3. Expression of a Dominant-Negative BMP Receptor Affects Bone Formation 
To confirm this requirement for BMP signaling at late stages, we also used the transgenic line 
Tg(hsp70l:dnBmpr-GFP)w30 harbouring a heat-shock inducible gene for a fusion protein between  
a dominant negative BMP receptor and the GFP. We performed a heat shock at 37 °C during 30 min at 
2 dpf and compared the head skeleton at 5 dpf of the transgenic larvae to that of their non-transgenic 
siblings (Figure 5A–C), as determined by their expression of the GFP fusion protein. While all control 
larvae formed a perfectly normal skeleton, indicating that the heat shock itself had no effect, the 
transgenic larvae (positive for GFP expression) producing the active dominant negative BMP receptor 
presented a clear decrease of bone calcification. This effect was strongest in those individuals presenting 
the highest GFP expression. When heat shock on Tg(hsp70l:dnBmpr-GFP)w30 was performed after  
48 hpf, 123 of 129 larvae presented normal cartilage (data not shown). These results clearly confirm 
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that BMP signaling is required for bone formation between 48 hpf and 72 hpf, without affecting 
cartilage formation. 
 
Figure 5. Effects caused by expression of the dominant negative Bmpr on bone formation. 
(A–C) Alizarin red staining of 5 dpf larvae after heat-shock treatment at 2 or 3 dpf. The 
extent of GFP expression 2 h after treatment indicates the transgenic status of the larva; 
GFP(−) being non-transgenic, GFP(++) transgenic, GFP(+++) being homozygous transgenic 
or larvae highly expressing the transgene (dnBmpr-GFP); (D–F) DAF-FM DA staining  
for nitric oxide detection in 5 dpf larvae (note that GFP fluorescence has disappeared at 
this time); (G–I) Red fluorescence allowing detection of mCherry-expressing osteoblasts  
c: cleithrum; en: entopterygoid; o: operculum; p: parasphenoid. Scale bar: 200 µM.  
(J,K) Statistical analysis of replicate experiments investigating the effect of dnBmpr 
expression on nitric oxide (J) or mCherry (K) detection. * indicates p-value < 0.05. 
We further investigated the extent of osteoblast differentiation by crossing parents of the 
Tg(hsp70l:dnBmpr-GFP)w30 with those of the Tg(osterix:mCherry) line and by inducing dnBmpr 
expression in the larvae by heat shock at 48 hpf. We observed no significant difference in mCherry 
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expression in the double transgenic larvae (Figure 5G–I,K), thus confirming that inhibition of BMP 
signaling after 48 hpf does not affect osteoblast formation. In contrast, NO detection in the same 
animals revealed a significant decrease of osteoblast activity at 5 dpf in the transgenic animals after 
heat shock at 2 dpf (note that the fluorescence of the dnBmpr-GFP fusion protein observed at 2–3 dpf 
is nearly absent at 5 dpf, except in the lens) (Figure 5D–F,J). 
3. Discussion 
The role of BMP/TGFβ ligands and/or antagonists in early embryonic development has been 
extensively documented in fundamental processes such as dorso-ventral patterning or establishment of 
left-right asymmetry [32–34]. Accordingly, many studies on the function and modulation of BMP signaling 
have concentrated on early stages of development, also concerning skeletal development [12,35]. 
Recent studies showed the involvement of BMP signals in cNCC migration and induction of  
pre-chondrocyte determination both in mouse [36] and in zebrafish around 12 hpf [37]. Later, at  
post-migratory cNCC stages in zebrafish (20–24 hpf), local BMP sources control the dorso-ventral 
patterning of the cranial skeleton [23,38]. Finally, BMP signaling was shown to be required around 
30–36 hpf for induction of the runx2b gene in the differentiating chondrocytes, while inhibition of the 
BMP pathway at 48 hpf did not affect chondrocranium formation [39]. 
Based on these results, we investigated the role of BMP signaling at these later stages on cranial 
bone formation, osteoblast differentiation, and bone mineralization. Using two different BMP inhibitors, 
dorsomorphin [24] and K02288 [28], we show that BMP signaling is required between 48 and 72 hpf, 
and to a lesser extent between 72 and 96 hpf, for cranial bone ossification as revealed by alizarin red 
staining of the bone matrix. This result was confirmed by inducing the expression of a dominant-negative 
Bmp receptor [40] at 48 or 72 hpf. Note that we observed expression of the dnBmpr-GFP fusion 
protein through its green fluorescence already 2 h after the heat shock, indicating that the delay caused 
by transcription-translation is minimal. Taken together, these observations define the period between 
48–72 hpf as the most crucial for BMP induction of ossification in the head skeleton. To further 
characterize the function of BMP signaling during these later stages, we investigated the differentiation 
and function of the osteoblasts upon pathway inhibition. Both the treatment with chemical inhibitors 
and expression of a dominant negative receptor only marginally affected the number of Osterix-expressing 
osteoblasts in the head of 5 dpf larvae, indicating that both proliferation and differentiation of these 
cells does not significantly depend on BMP signaling during this period. 
Members of the TGFβ family have also been shown to be involved in zebrafish early cartilage 
development, such as Tgfβ2 [41] and Tgfβ3 [42]. Although these studies were performed using antisense 
morpholino injection and thus blocked gene expression from very early on, these factors may also 
affect skeletal development at later stages as studied here. The K02288 inhibitor is more than 100-fold 
more potent against BMP receptors ALK1 and ALK2 as compared to TGFß receptors ALK4 and 
ALK5 [28], while we found no evidence that the dnBmpr could interact with ALK4 or ALK5, 
therefore we think that the results presented here are due to inhibition of BMP signaling. Future studies 
may use specific TGFβ inhibitors to investigate the function of these factors in late skeletogenesis. 
Nitric oxide (NO) has long been associated to bone development and pathologies [43,44]. 
Pharmacological inhibition of nitrogen oxide synthases (NOS) enzymes in rats leads to a decreased 
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bone mass [45] and impairment of tibial growth [46], while mice deficient in endothelial NOS (eNOS) 
present reduced bone volume and severe defects in osteoblast maturation and activity [47,48]. NO 
production by osteoblasts has been associated with pathological conditions, such as inflammatory bone 
loss through activation of the cGMP/protein kinase G (PKG) pathway inducing Runx2 expression  
and production of matrix metalloproteinase MMP13 [44,49,50]. Bone cells are also known to react to 
mechanical or shear stress by producing nitric oxide [51–53], while NO action in shear stressed human 
and mouse osteoblasts was shown to result in activation of PKG, the intracellular protein kinases Src 
and Akt [54] finally inducing nuclear translocation of β-catenin [55]. Similarly, early osteogenic 
differentiation of murine embryonic stem cells as well as their mineralization was shown to be enhanced 
by NO, acting on ß-catenin and involving the canonical Wnt pathway [56]. 
In zebrafish, inhibition of BMP signaling between 48–72 hpf did not significantly affect osteoblast 
differentiation. In contrast, production of nitric oxide was clearly decreased in the treated animals. This 
observation, together with the observed decrease in cranial bone mineralization, leads to the conclusion 
that NO production in developing cranial osteoblasts in zebrafish is closely associated to bone calcification. 
4. Experimental Section 
4.1. Fish and Embryo Maintenance 
Zebrafish (Danio rerio) were reared in a recirculating system from Techniplast (Buguggiate, Italy) at a 
maximal density of 7 fish/L. The water characteristics were as follows: pH = 7.4, conductivity = 50 mS/m 
temperature = 28 °C. The light cycle was controlled (14 h light, 10 h dark). Fish were fed twice daily 
with dry powder (ZM fish food®, Zebrafish Management Ltd, Winchester, UK) with size adapted to 
their age, and once daily with fresh nauplii from Artemia salina (ZM fish food®). Larvae aged less than 
14 days were also fed twice daily with a live paramecia culture. Wild type embryos from the AB strain 
were used and staged according to Kimmel [57]. The transgenic line Tg(hsp70l:dnBmpr-GFP) [40] 
was obtained from the Zebrafish International Research Center (ZIRC, Eugene, OR, USA). 
Tg(osterix:mCherry) transgenic zebrafish have been generated as described earlier [4,29,30]. 
The day before breeding, two males and two females were placed in breeding tanks out of the 
recirculating system, with an internal divider to prevent unwanted mating. On the day of breeding, fish 
were placed in fresh aquarium water and the divider was removed to allow mating. Eggs were raised in 
E3 (5 mM Na Cl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, 0.00001% methylene blue). 
4.2. Alcian Blue and Alizarin Red Staining 
Cartilage and bone staining using alcian blue (CAS No: 33864-99-2) and alizarin red S (CAS No: 
130-22-3, Sigma-Aldrich, Diegem, Belgium), respectively, on fixed specimen were performed as 
previously described [58]. 
4.3. Inhibition of Bmp Signaling 
Transgenic embryos hsp70l:dnBmpr-GFP [40] were heat shocked at desired stages by placing them 
into a water bath for 30 min at 37 °C and afterward placed back at 28 °C. Two hours after the heat 
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shock, the embryos were screened for GFP fluorescence. Embryos not expressing GFP were used as 
non-transgenic controls. 
Inhibition of Bmp signaling 10 mM stock solution of dorsomorphin (CAS No: 1219168-18-9) 
(Sigma-Aldrich), K02288 (CAS No: 1431985-92-0) (Tocris Bioscience®, Lille, France) was diluted in 
DMSO (Merck Chemicals, Overijse, Belgium). Embryos at desired stage were placed into 6-well 
plates with the inhibitor diluted in E3 rearing medium at the desired concentration during a specific 
time period. DMSO alone was used as control (1% for dorsomorphin 100 µM and 0.1% and 0.2% for 
K02288 10 µM and 20 µM respectively). Embryos were then rinsed several times with E3, raised in E3 
and finally fixed at the desired stage. 
All experiments were performed on at least 20 individuals and repeated at least three times. Images 
shown in the figures are representative for more than 95% of the larvae observed under the respective 
conditions. Staining intensity was evaluated based on overall intensity, and focusing on the less 
intensely stained elements. 
4.4. Living Nitric Oxide Labeling 
For labeling of nitric oxide (NO), DAF-FM DA stock (CAS No: 254109-22-3) (Alexis corporation, 
Lausen, Switzerland; 5 mM in DMSO) has been diluted 1:1000 in E3 zebrafish medium and larvae were 
incubated over night at 28 °C in the dark and rinsed several times before imaging as previously 
described [29,59]. 
4.5. Whole-Mount in Situ Hybridization (WISH) 
Whole mount in situ hybridization was performed as previously described [60]. The antisense RNA 
probe for sox9a [61] was synthesized by transcription of cDNA clones with T7, T3 or SP6 RNA 
polymerase using digoxigenin labeling mix (Roche Diagnostics, Meylan, France). Treated and  
non-treated larvae were fixed at 5 dpf in PFA 4%. In situ labeling was observed using an Olympus SZX10 
stereomicroscope (Olympus, Berchem, Belgium) coupled with an Olympus XC50 camera. 
4.6. Image Aquisition 
All images were taken on a SZX10 stereomicroscope driven by the CELL B software (Olympus). 
Fluorescent images for nitric oxide labeling and transgenic mCherry expression were obtained using 
GFPA (Exc.: 460–490, Em.: 510–550) and RFP (Exc.: 540–580, Em.: 610) filters, respectively. For live 
imaging, embryos were anaesthetized with tricaine (Sigma-Aldrich) until they showed sufficiently  
low movement. 
Quantification of fluorescence was performed using the ImageJ software [62] by first isolating the 
red or green channel, followed by integration of the pixel intensity on the resulting grey scale image. 
For nitric oxide labeling, the integrated density of the heart was subtracted, as this staining does not 
correspond to osteoblasts. The obtained numbers were normalized by dividing all values by the mean 
value obtained for the control larvae, and statistical significance of the observed differences was 
evaluated using a two-tailed t-test. 
  




In conclusion, we show here that BMP signaling is of major importance for cranial bone formation 
in zebrafish between 48–72 hpf, with only minor effects on osteoblast proliferation and differentiation, 
but mainly by affecting bone mineralization through induction of osteoblast activity as visualized by 
their production of nitric oxide. Further, it appears that detection of nitric oxide in developing zebrafish 
larvae may be an early indicator of bone calcification activity. 
Supplementary Materials 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/20/05/7586/s1. 
Acknowledgments 
This work was supported by the “Fonds de la Recherche Fondamentale Collective”; 
2.4555.99/2.4542.00/2.4561.10, the SSTC; the European Space Agency, the Belgian Space Agency 
Prodex. T.W. was supported by F.N.R.S, J.R. by ESA and M.M. is a “Chercheur Qualifié du F.N.R.S.” 
We wish to thank the GIGA-R zebrafish facility for providing zebrafish adults and fertilized eggs and 
the GIGA-R GenoTranscriptomics platform for DNA sequencing. 
Author Contributions 
T.W.; S.S.: all experiments, writing; J.R.; M.M.: planning, supervision and writing. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Schilling, T.F.; Kimmel, C.B. Segment and cell type lineage restrictions during pharyngeal arch 
development in the zebrafish embryo. Development 1994, 120, 483–494. 
2. Hammond, C.L.; Schulte-Merker, S. Two populations of endochondral osteoblasts with differential 
sensitivity to hedgehog signalling. Development 2009, 136, 3991–4000. 
3. Flores, M.V.; Lam, E.Y.; Crosier, P.; Crosier, K. A hierarchy of runx transcription factors 
modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish. Dev. Dyn. 
2006, 235, 3166–3176. 
4. Spoorendonk, K.M.; Peterson-Maduro, J.; Renn, J.; Trowe, T.; Kranenbarg, S.; Winkler, C.; 
Schulte-Merker, S. Retinoic acid and cyp26b1 are critical regulators of osteogenesis in the axial 
skeleton. Development 2008, 135, 3765–3774. 
5. Gavaia, P.J.; Simes, D.C.; Ortiz-Delgado, J.B.; Viegas, C.S.; Pinto, J.P.; Kelsh, R.N.;  
Sarasquete, M.C.; Cancela, M.L. Osteocalcin and matrix gla protein in zebrafish (Danio rerio) and 
senegal sole (Solea senegalensis): Comparative gene and protein expression during larval 
development through adulthood. Gene Expr. Patterns 2006, 6, 637–652. 
Molecules 2015, 20 7598 
 
 
6. Li, N.; Felber, K.; Elks, P.; Croucher, P.; Roehl, H.H. Tracking gene expression during zebrafish 
osteoblast differentiation. Dev. Dyn. 2009, 238, 459–466. 
7. Apschner, A.; Schulte-Merker, S.; Witten, P.E. Not all bones are created equal—Using zebrafish 
and other teleost species in osteogenesis research. Methods Cell Biol. 2011, 105, 239–255. 
8. Vanoevelen, J.; Janssens, A.; Huitema, L.F.; Hammond, C.L.; Metz, J.R.; Flik, G.; Voets, T.; 
Schulte-Merker, S. Trpv5/6 is vital for epithelial calcium uptake and bone formation. FASEB J. 
2011, 25, 3197–3207. 
9. Huitema, L.F.; Apschner, A.; Logister, I.; Spoorendonk, K.M.; Bussmann, J.; Hammond, C.L.; 
Schulte-Merker, S. Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis 
in zebrafish. Proc. Natl. Acad. Sci. USA 2012, 109, 21372–21377. 
10. Apschner, A.; Huitema, L.F.; Ponsioen, B.; Peterson-Maduro, J.; Schulte-Merker, S. Zebrafish 
enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial 
calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE). Dis. Models Mech. 2014, 
7, 811–822. 
11. Poulain, M.; Furthauer, M.; Thisse, B.; Thisse, C.; Lepage, T. Zebrafish endoderm formation is 
regulated by combinatorial nodal, fgf and bmp signalling. Development 2006, 133, 2189–2200. 
12. Nie, X.; Luukko, K.; Kettunen, P. Bmp signalling in craniofacial development. Int. J. Dev. Biol. 
2006, 50, 511–521. 
13. Massague, J.; Gomis, R.R. The logic of TGFβ signaling. FEBS Lett. 2006, 580, 2811–2820. 
14. Dudas, M.; Sridurongrit, S.; Nagy, A.; Okazaki, K.; Kaartinen, V. Craniofacial defects in mice 
lacking BMP type i receptor Alk2 in neural crest cells. Mech. Dev. 2004, 121, 173–182. 
15. Ko, S.O.; Chung, I.H.; Xu, X.; Oka, S.; Zhao, H.; Cho, E.S.; Deng, C.; Chai, Y. Smad4 is required 
to regulate the fate of cranial neural crest cells. Dev. Biol. 2007, 312, 435–447. 
16. Tang, S.; Snider, P.; Firulli, A.B.; Conway, S.J. Trigenic neural crest-restricted smad7 over-expression 
results in congenital craniofacial and cardiovascular defects. Dev. Biol. 2010, 344, 233–247. 
17. Lee, M.H.; Kim, Y.J.; Kim, H.J.; Park, H.D.; Kang, A.R.; Kyung, H.M.; Sung, J.H.; Wozney, J.M.; 
Kim, H.J.; Ryoo, H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes 
the Bmp-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 
2003, 278, 34387–34394. 
18. Lee, M.H.; Kwon, T.G.; Park, H.S.; Wozney, J.M.; Ryoo, H.M. Bmp-2-induced osterix expression 
is mediated by dlx5 but is independent of runx2. Biochem. Biophys. Res. Commun. 2003, 309, 
689–694. 
19. Asharani, P.V.; Keupp, K.; Semler, O.; Wang, W.; Li, Y.; Thiele, H.; Yigit, G.; Pohl, E.; Becker, J.; 
Frommolt, P.; et al. Attenuated bmp1 function compromises osteogenesis, leading to bone 
fragility in humans and zebrafish. Am. J. Hum. Genet. 2012, 90, 661–674. 
20. Holzschuh, J.; Wada, N.; Wada, C.; Schaffer, A.; Javidan, Y.; Tallafuss, A.; Bally-Cuif, L.; 
Schilling, T.F. Requirements for endoderm and bmp signaling in sensory neurogenesis in zebrafish. 
Development 2005, 132, 3731–3742. 
21. Martinez-Barbera, J.P.; Toresson, H.; Da Rocha, S.; Krauss, S. Cloning and expression of three 
members of the zebrafish bmp family: Bmp2a, bmp2b and bmp4. Gene 1997, 198, 53–59. 
22. Wilson, J.; Tucker, A.S. Fgf and bmp signals repress the expression of bapx1 in the mandibular 
mesenchyme and control the position of the developing jaw joint. Dev. Biol. 2004, 266, 138–150. 
Molecules 2015, 20 7599 
 
 
23. Alexander, C.; Zuniga, E.; Blitz, I.L.; Wada, N.; Le Pabic, P.; Javidan, Y.; Zhang, T.; Cho, K.W.; 
Crump, J.G.; Schilling, T.F. Combinatorial roles for bmps and endothelin 1 in patterning the 
dorsal-ventral axis of the craniofacial skeleton. Development 2011, 138, 5135–5146. 
24. Hao, J.; Daleo, M.A.; Murphy, C.K.; Yu, P.B.; Ho, J.N.; Hu, J.; Peterson, R.T.; Hatzopoulos, A.K.; 
Hong, C.C. Dorsomorphin, a selective small molecule inhibitor of bmp signaling, promotes 
cardiomyogenesis in embryonic stem cells. PLoS ONE 2008, 3, e2904. 
25. Boergermann, J.H.; Kopf, J.; Yu, P.B.; Knaus, P. Dorsomorphin and ldn-193189 inhibit  
bmp-mediated smad, p38 and akt signalling in c2c12 cells. Int. J. Biochem. Cell Biol. 2010, 42, 
1802–1807. 
26. Yu, P.B.; Deng, D.Y.; Lai, C.S.; Hong, C.C.; Cuny, G.D.; Bouxsein, M.L.; Hong, D.W.; 
McManus, P.M.; Katagiri, T.; Sachidanandan, C.; et al. Bmp type i receptor inhibition reduces 
heterotopic [corrected] ossification. Nat. Med. 2008, 14, 1363–1369. 
27. Hao, J.; Ho, J.N.; Lewis, J.A.; Karim, K.A.; Daniels, R.N.; Gentry, P.R.; Hopkins, C.R.;  
Lindsley, C.W.; Hong, C.C. In vivo structure-activity relationship study of dorsomorphin analogues 
identifies selective vegf and bmp inhibitors. ACS Chem. Biol. 2010, 5, 245–253. 
28. Sanvitale, C.E.; Kerr, G.; Chaikuad, A.; Ramel, M.C.; Mohedas, A.H.; Reichert, S.; Wang, Y.; 
Triffitt, J.T.; Cuny, G.D.; Yu, P.B.; et al. A new class of small molecule inhibitor of bmp signaling. 
PLoS ONE 2013, 8, e62721. 
29. Renn, J.; Pruvot, B.; Muller, M. Detection of nitric oxide by diaminofluorescein visualizes the 
skeleton in living zebrafish. J. Appl. Ichthyol. 2014, 30, 701–706. 
30. Renn, J.; Winkler, C. Osterix-mcherry transgenic medaka for in vivo imaging of bone formation. 
Dev. Dyn. 2009, 238, 241–248. 
31. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.; Deng, J.M.; Behringer, R.R.; de Crombrugghe, B. 
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation 
and bone formation. Cell 2002, 108, 17–29. 
32. Wang, R.N.; Green, J.; Wang, Z.; Deng, Y.; Qiao, M.; Peabody, M.; Zhang, Q.; Ye, J.; Yan, Z.; 
Denduluri, S.; et al. Bone morphogenetic protein (BMP) signaling in development and human 
diseases. Genes Dis. 2014, 1, 87–105. 
33. Chen, D.; Zhao, M.; Mundy, G.R. Bone morphogenetic proteins. Growth Factors 2004, 22, 233–241. 
34. Schilling, T.F.; Concordet, J.P.; Ingham, P.W. Regulation of left-right asymmetries in the 
zebrafish by shh and bmp4. Dev. Biol. 1999, 210, 277–287. 
35. Wan, M.; Cao, X. Bmp signaling in skeletal development. Biochem. Biophys. Res. Commun. 
2005, 328, 651–657. 
36. Bonilla-Claudio, M.; Wang, J.; Bai, Y.; Klysik, E.; Selever, J.; Martin, J.F. Bmp signaling 
regulates a dose-dependent transcriptional program to control facial skeletal development. 
Development 2012, 139, 709–719. 
37. Das, A.; Crump, J.G. Bmps and id2a act upstream of twist1 to restrict ectomesenchyme potential 
of the cranial neural crest. PLoS Genet. 2012, 8, e1002710. 
38. Zuniga, E.; Rippen, M.; Alexander, C.; Schilling, T.F.; Crump, J.G. Gremlin 2 regulates distinct 
roles of bmp and endothelin 1 signaling in dorsoventral patterning of the facial skeleton. 
Development 2011, 138, 5147–5156. 
Molecules 2015, 20 7600 
 
 
39. Dalcq, J.; Pasque, V.; Ghaye, A.; Larbuisson, A.; Motte, P.; Martial, J.A.; Muller, M. Runx3, egr1 
and sox9b form a regulatory cascade required to modulate bmp-signaling during cranial cartilage 
development in zebrafish. PLoS ONE 2012, 7, e50140. 
40. Pyati, U.J.; Webb, A.E.; Kimelman, D. Transgenic zebrafish reveal stage-specific roles for bmp 
signaling in ventral and posterior mesoderm development. Development 2005, 132, 2333–2343. 
41. Swartz, M.E.; Sheehan-Rooney, K.; Dixon, M.J.; Eberhart, J.K. Examination of a palatogenic 
gene program in zebrafish. Dev. Dyn. 2011, 240, 2204–2220. 
42. Cheah, F.S.; Winkler, C.; Jabs, E.W.; Chong, S.S. TGFβ3 regulation of chondrogenesis and 
osteogenesis in zebrafish is mediated through formation and survival of a subpopulation of the 
cranial neural crest. Mech. Dev. 2010, 127, 329–344. 
43. Evans, D.M.; Ralston, S.H. Nitric oxide and bone. J. Bone Miner. Res. 1996, 11, 300–305. 
44. Van’t Hof, R.J.; Ralston, S.H. Nitric oxide and bone. Immunology 2001, 103, 255–261. 
45. Tsukahara, H.; Miura, M.; Tsuchida, S.; Hata, I.; Hata, K.; Yamamoto, K.; Ishii, Y.; Muramatsu, I.; 
Sudo, M. Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats.  
Am. J. Physiol. 1996, 270, E840–E845. 
46. Turner, C.H.; Owan, I.; Jacob, D.S.; McClintock, R.; Peacock, M. Effects of nitric oxide synthase 
inhibitors on bone formation in rats. Bone 1997, 21, 487–490. 
47. Aguirre, J.; Buttery, L.; O’Shaughnessy, M.; Afzal, F.; Fernandez de Marticorena, I.; Hukkanen, M.; 
Huang, P.; MacIntyre, I.; Polak, J. Endothelial nitric oxide synthase gene-deficient mice demonstrate 
marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast 
maturation and activity. Am. J. Pathol. 2001, 158, 247–257. 
48. Armour, K.E.; Armour, K.J.; Gallagher, M.E.; Godecke, A.; Helfrich, M.H.; Reid, D.M.;  
Ralston, S.H. Defective bone formation and anabolic response to exogenous estrogen in mice with 
targeted disruption of endothelial nitric oxide synthase. Endocrinology 2001, 142, 760–766. 
49. Ralston, S.H.; Grabowski, P.S. Mechanisms of cytokine induced bone resorption: Role of nitric 
oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 1996, 19, 29–33. 
50. Saura, M.; Tarin, C.; Zaragoza, C. Recent insights into the implication of nitric oxide in osteoblast 
differentiation and proliferation during bone development. Sci. World J. 2010, 10, 624–632. 
51. Bacabac, R.G.; Smit, T.H.; Mullender, M.G.; Dijcks, S.J.; Van Loon, J.J.; Klein-Nulend, J. Nitric 
oxide production by bone cells is fluid shear stress rate dependent. Biochem. Biophys. Res. Commun. 
2004, 315, 823–829. 
52. Bakker, A.D.; Soejima, K.; Klein-Nulend, J.; Burger, E.H. The production of nitric oxide and 
prostaglandin E2 by primary bone cells is shear stress dependent. J. Biomech. 2001, 34, 671–677. 
53. Pitsillides, A.A.; Rawlinson, S.C.; Suswillo, R.F.; Bourrin, S.; Zaman, G.; Lanyon, L.E. 
Mechanical strain-induced no production by bone cells: A possible role in adaptive bone 
(re)modeling? FASEB J. 1995, 9, 1614–1622. 
54. Rangaswami, H.; Schwappacher, R.; Marathe, N.; Zhuang, S.; Casteel, D.E.; Haas, B.; Chen, Y.; 
Pfeifer, A.; Kato, H.; Shattil, S.; et al. Cyclic gmp and protein kinase g control a src-containing 
mechanosome in osteoblasts. Sci. Signal. 2010, 3, ra91. 
55. Rangaswami, H.; Schwappacher, R.; Tran, T.; Chan, G.C.; Zhuang, S.; Boss, G.R.; Pilz, R.B. 
Protein kinase g and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in 
osteoblast mechanotransduction. J. Biol. Chem. 2012, 287, 21509–21519. 
Molecules 2015, 20 7601 
 
 
56. Ding, H.; Keller, K.C.; Martinez, I.K.; Geransar, R.M.; zur Nieden, K.O.; Nishikawa, S.G.; 
Rancourt, D.E.; zur Nieden, N.I. No-β-catenin crosstalk modulates primitive streak formation 
prior to embryonic stem cell osteogenic differentiation. J. Cell Sci. 2012, 125, 5564–5577. 
57. Kimmel, C.B.; Ballard, W.W.; Kimmel, S.R.; Ullmann, B.; Schilling, T.F. Stages of embryonic 
development of the zebrafish. Dev. Dyn. 1995, 203, 253–310. 
58. Walker, M.B.; Kimmel, C.B. A two-color acid-free cartilage and bone stain for zebrafish larvae. 
Biotech. Histochem. 2007, 82, 23–28. 
59. Lepiller, S.; Laurens, V.; Bouchot, A.; Herbomel, P.; Solary, E.; Chluba, J. Imaging of nitric oxide 
in a living vertebrate using a diamino-fluorescein probe. Free Radic Biol. Med. 2007, 43, 619–627. 
60. Hauptmann, G.; Gerster, T. Multicolor whole-mount in situ hybridization. Methods Mol. Biol. 
2000, 137, 139–148. 
61. Yan, Y.L.; Miller, C.T.; Nissen, R.M.; Singer, A.; Liu, D.; Kirn, A.; Draper, B.; Willoughby, J.; 
Morcos, P.A.; Amsterdam, A.; et al. A zebrafish sox9 gene required for cartilage morphogenesis. 
Development 2002, 129, 5065–5079. 
62. ImageJ: Image Processing and Analysis in Java. Natioanl Institutes of Health, Bethesda, MD, 
USA. Available online: http://imagej.nih.gov/ (accessed on 20 April 2015). 
Sample Availability: All compounds are commercially available. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
